DNA methylation as a marker of response in rheumatoid arthritis.

Abstract excerpt

Rheumatoid arthritis (RA) is a complex disease affecting approximately 0.5-1% of the population. While there are effective biologic therapies, in up to 40% of patients, disease activity remains inadequately controlled. Therefore, identifying factors that predict, prior to the initiation of therapy, which patients are likely to respond best to which treatment is a research priority and DNA methylation is...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adrenal Cortex Hormones
• Share to Anti-Inflammatory Agents, Non-Steroidal
• Share to Antibodies, Monoclonal